Local dose-effect relations for lung perfusion post stereotactic body radiotherapy.

[1]  R. Mohan,et al.  Predicting pneumonitis risk: a dosimetric alternative to mean lung dose. , 2013, International journal of radiation oncology, biology, physics.

[2]  R. D. de Boer,et al.  Physiological interaction of heart and lung in thoracic irradiation. , 2012, International journal of radiation oncology, biology, physics.

[3]  J. Sonke,et al.  Relating Acute Esophageal Toxicity to Radiation Therapy Dose Using 18FDG-PET in Concurrent Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer , 2012 .

[4]  J. Sonke,et al.  Is There a Lower Limit of Pretreatment Pulmonary Function for Safe and Effective Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer? , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  E. Steyerberg,et al.  [Regression modeling strategies]. , 2011, Revista espanola de cardiologia.

[6]  Matthias Guckenberger,et al.  Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Ke Sheng,et al.  Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[8]  M. Martel,et al.  Radiation dose-volume effects in the lung. , 2010, International journal of radiation oncology, biology, physics.

[9]  R. Jaszczak,et al.  Radiation-induced reductions in regional lung perfusion: 0.1-12 year data from a prospective clinical study. , 2010, International journal of radiation oncology, biology, physics.

[10]  R. Barriger,et al.  A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy. , 2009, International journal of radiation oncology, biology, physics.

[11]  Lech Papiez,et al.  Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. , 2009, International journal of radiation oncology, biology, physics.

[12]  Jan Nyman,et al.  Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Jan-Jakob Sonke,et al.  Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance. , 2009, International journal of radiation oncology, biology, physics.

[14]  Jan-Jakob Sonke,et al.  Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  E. Smit,et al.  Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.

[16]  R. Timmerman,et al.  Stereotactic Body Radiation Therapy: A Comprehensive Review , 2007, American journal of clinical oncology.

[17]  Jan-Jakob Sonke,et al.  Mid-ventilation CT scan construction from four-dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients. , 2006, International journal of radiation oncology, biology, physics.

[18]  Jan Nyman,et al.  Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries , 2006, Acta oncologica.

[19]  Masahiro Hiraoka,et al.  Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. , 2005, International journal of radiation oncology, biology, physics.

[20]  Joos V Lebesque,et al.  Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. , 2003, International journal of radiation oncology, biology, physics.

[21]  Y Seppenwoolde,et al.  Partial irradiation of the lung. , 2001, Seminars in radiation oncology.

[22]  Frank E. Harrell,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .

[23]  L. Boersma,et al.  Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer. , 2000, International journal of radiation oncology, biology, physics.

[24]  P Baas,et al.  Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer. , 2000, International journal of radiation oncology, biology, physics.

[25]  R K Ten Haken,et al.  Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. , 1998, International journal of radiation oncology, biology, physics.

[26]  L. Boersma,et al.  Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  R. Jaszczak,et al.  Quantification of radiation-induced regional lung injury with perfusion imaging. , 1997, International journal of radiation oncology, biology, physics.

[28]  L. Boersma,et al.  Recovery of overall and local lung function loss 18 months after irradiation for malignant lymphoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  L. Boersma,et al.  Dose-effect relations for local functional and structural changes of the lung after irradiation for malignant lymphoma. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  J. Lebesque,et al.  The simultaneous boost technique: the concept of relative normalized total dose. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  C. Burman,et al.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.

[32]  H. Akaike.  A new look at the statistical model identification , 1974 .

[33]  Jan-Jakob Sonke,et al.  Relating acute esophagitis to radiotherapy dose using FDG-PET in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  Zhongxing Liao,et al.  Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  E. Glatstein,et al.  Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer , 2008 .

[36]  J. Lebesque,et al.  Prospective assessment of dosimetric/physiologic- based models for predicting radiation pneumonitis , 2009 .

[37]  R. Jaszczak,et al.  The time course of radiation therapy-induced reductions in regional perfusion: a prospective study with >5 years of follow-up. , 2002, International journal of radiation oncology, biology, physics.

[38]  J. Lyman.  Complication probability as assessed from dose-volume histograms. , 1985, Radiation research. Supplement.